http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-20002455-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 |
| filingDate | 1998-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdac91fc5a325f887f8fd2acb3d9e900 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e4edbb0c5e4b09a7b9fcc6666b81f87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9359e4425bc5bd8f14421b7f2fe6232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e5f4aebe63347ce36817d9a03eccbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_894abc2063262de1c754fa2662578a98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f5f9c8921885b5d6c96c3a18c8da774 |
| publicationDate | 2001-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-20002455-A3 |
| titleOfInvention | 2,3-Substituted indoles, pharmaceutical compositions based thereon, a method of treatment and methods of manufacture |
| abstract | 2,3-Substituted Indoles of Formula I wherein Znrepresents a hydroxy group, an alkoxy group having 1 to 6 atomsncarbon, -NR 2 R 3 or heterocycle; Q representsnoptionally substituted phenyl, (b) optionallynsubstituted 6-membered monocyclic aromaticna group having 1, 2, 3 or 4 nitrogen atoms, (c) optionallynsubstituted 5-membered monocyclic aromaticna group containing one heteroatom selected from oxygen, sulfur andnnitrogen which optionally contains itn1, 2 or 3 nitrogen atoms, (d) optionally substitutednC 3 -C 7 cycloalkyl; and (e) optionallynsubstituted benzo-fused heterocycle; R * 1 representsnhydrogen, (C 1 -C 4) alkyl or halogen; R2 anR3 is each independently hydrogen, hydroxy,n(C 1 -C 4) alkoxy, (C 1 -C 4) alkyl groupncarbon atoms or C 1 -C 4 alkylnsubstituted with halogen, hydroxy, alkoxynC 1 -C 4 or CN; X represents independently atneach occurrence of hydrogen, halogen, alkyl of 1 to 4ncarbon atoms, halo-substituted (C 1 -C 4) alkyl, hydroxy, (1-4C) alkoxyncarbon, a halo-substituted alkoxy group having 1 to 4 atomsncarbon, C 1 -C 4 alkylthio, NO 2,nNH 2, di (alkyl) amino of 1 to 4 carbon atoms in each ofnalkyl moieties or CN; and n is 0, 1, 2, 3 orn4. Pharmaceutical compositions useful for treatmentnmedical conditions for which pathogens are considerednprostagladins, and a method of treating such conditions. |
| priorityDate | 1998-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1616.